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Great progress has been made in achieving universal access to antiretroviral therapy (ART).
However, for successful viral suppression, patients must adhere to rigid and complex
treatment regimens. With three quarters of antiretroviral (ARV) users in Africa adhering
successfully, African countries have achieved extraordinary levels of adherence given the
levels of poverty in which many ARV users live. Nevertheless, one quarter of ARV users still
struggle to adhere and run the risk of experiencing viral replication, clinical progression or
even drug resistance. Much has been written about ART adherence, but little has been done
to systematically categorise the spectrum of factors that inﬂuence ART. In this paper, we use
a Zimbabwean case study to develop a framework for ART programme planners and
implementers seeking to identify and tackle social obstacles to adherence. We draw on
interviews and group discussions with 25 nurses and 53 adult ARV users, which we analysed
through a three‐tiered thematic approach, allowing us to categorise our ﬁndings into broader
dimensions that can transcend our case study and be applied elsewhere. Our ﬁndings suggest
that ART adherence is inﬂuenced by the material, symbolic, relational and institutional
contexts in which ARV users live as well as the patient’s motivation, participation and
psychosocial responses to ART. This framework allows us to examine both the social context
in which ART programmes are located and the psychosocial factors that inﬂuence patient
behaviours. We offer this framework as a resource for ART programme planners and
implementers seeking to improve ART compliance in resource‐poor settings. Copyright ©
2011 John Wiley & Sons, Ltd.
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297INFLUENCES ON ART ADHERENCE IN RURAL ZIMBABWEINTRODUCTION
Thanks to the planning and extraordinary management of national health departments
in sub‐Saharan Africa and their partners, the last couple of years have seen rapid
progress in scaling up antiretroviral therapy (ART) for people living with HIV and
AIDS (PLWHA) in the region (WHO et al., 2009). It is estimated that 44% of
Africans with advanced HIV infection are currently receiving ART (WHO, 2010).
However, ART programme planners and implementers should not measure their
success through the number of people receiving ART at a given time but also take into
account their patients’ successful compliance to treatment. The virologic efﬁcacy of
ART, or ‘good adherence’, is better achieved if patients stick to their treatment
regimen for 95% of the time (Attaran, 2007). In resource‐poor settings this is not easy
to achieve, and many fail to adhere in the long term (Rosen et al., 2007). Although
much work has been done to inform ART programme planners and implementers of
particular determinants and predictors of poor ART adherence, no efforts have yet
been made to develop a framework that allows them to analyse the spectrum of social
and behavioural factors inﬂuencing ART adherence. In this paper, we seek to
contribute to the development of such an analytical framework, believing this will
help ART programme planners and implementers to pinpoint possible obstacles and
facilitators to adherence. To do this, we ‘mined’ our user‐service interface study for
any information that threw light on factors facilitating or hindering adherence. On the
basis of a ‘grounded theory’ analysis of the views of ART users and providers in rural
Zimbabwe—a country where no other study on ART adherence has yet been carried
out—two levels of analysis emerged, namely, the contextual and psychosocial.
The ART adherence rate in sub‐Saharan Africa compares favourably with that in
North America (Mills et al., 2006a, 2006b). However, virologic failure still occurs
in settings with otherwise high levels of reported adherence (Bisson et al., 2008),
raising questions about how adherence is measured and monitored (Chalker et al.,
2008). The time frame in which adherence is measured must be considered. A
review of the literature, for example, found that only 60% of ART users in sub‐
Saharan Africa were still enrolled onto an ART programme after 2 years (Rosen
et al., 2007). This, coupled with less successful programmes going unreported (Gill
et al., 2005) and numerous studies continuing to report poor levels of adherence
(Uzochukwu et al., 2009), suggests that there is no room for complacency in
addressing the factors that either facilitate or undermine ART adherence.
The majority of research on ART adherence in Africa is heavily focused on barriers.
The common barriers identiﬁed in both qualitative and quantitative studies include
stigma, treatment‐related costs, distance to and waiting times at health facilities,
perceptions of side effects, lack of food and inadequate knowledge of ART (Weiser
et al., 2003; Mshana et al., 2006; Hardon et al., 2007; Dahab et al., 2008; Posse et al.,
2008; Murray et al., 2009; Roura et al., 2009). However, also gender (Kempf et al.,
2009; Uzochukwu et al., 2009), alcohol use (Nachega et al., 2006; Dahab et al., 2008;
Fitzgerald et al., 2010), depression, hopelessness, psychopathology (Murray et al.,
2009; Adewuya et al., 2010), forgetfulness, complacency (Krebs et al., 2008) and
dissatisfaction with hospital facilities and staff (Mshana et al., 2006; Sanjobo et al.,
2008; Kip et al., 2009) have meant that some patients do not achieve optimalCopyright © 2011 John Wiley & Sons, Ltd. Int J Health Plann Mgmt 2011; 26: 296–318.
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of ART adherence, only a handful of studies have looked explicitly at the facilitators of
ART adherence (cf. Ware et al., 2009; Watt et al., 2009b). Some of the facilitators that
have been identiﬁed include encouragement from peers, perceived health beneﬁts,
hope and personal motivation (Roura et al., 2009), social support, treatment partners,
belief in value of treatment, living up to social responsibilities, opportunities to ﬁt ART
into a daily routine (Dahab et al., 2008; Ware et al., 2009), feeling better, having
knowledge about ART, engagement with income‐generating activities (IGAs),
disclosure of HIV status and praying (Sanjobo et al., 2008; Watt et al., 2009b).
It is clear that much information has been gathered to explain what factors may
facilitate and undermine ART adherence. However, it appears that many studies are
guided by health behaviour theories, often at the expense of how behaviours such as
ART adherence are enabled or supported by the wider social environments in which
behavioural decisions are made. The health behaviour theories that have been used
include the information, motivation and behavioural skills model (Peltzer et al.,
2010), the health belief model (cf. Wringe et al., 2009) and social cognitive theory
(cf. Watt et al., 2009a). All of these focus on the individual level of analysis, with
behaviour viewed as the outcome of conscious rational choice. In this paper, we
seek to move beyond a focus on individual behaviour shaped by cognitions such as
attitudes, beliefs and motivations, to improve our understandings of how the social
environment shapes the links between cognition and behaviour, with particular
attention to the way in which particular forms of behaviour are enabled or limited
within speciﬁc local contexts.
Some efforts have been made to examine ART adherence in relation to social
contexts, for example, by using socioecological theories (Posse et al., 2008; Roura
et al., 2009) and theories of social capital (Ware et al., 2009). Ware et al. (2009)
focused on the inﬂuence of social relations on adherence in Nigeria, Tanzania and
Uganda by highlighting the role of social relationships in facilitating adherence,
arguing that in conditions of chronic poverty, people on ART adhere in order to
ensure that family members who support them remain motivated to do so. Although
these theories help us get a little closer to understanding the behaviours that govern
ART adherence, they only provide us with a snapshot of a handful of factors in any
given context. It is against this background, and in view of our belief that healthcare‐
seeking behaviours are determined by social factors and not merely a result of
individual choices, that we seek to construct an analytical framework of the
spectrum of factors that inﬂuence ART adherence in Zimbabwe. In doing so, we
hope to contribute to the evolving ‘fourth generation’ model of AIDS management
outlined below.TOWARDS AN ANALYTICAL FRAMEWORK FOR UNDERSTANDING
ANTIRETROVIRAL THERAPY ADHERENCE
In their review of the evolution of approaches to promoting health‐enhancing HIV/
AIDS‐related behaviours in the ﬁeld of HIV prevention, Campbell and Cornish (2010)
identify three generations of approaches, namely, information provision, peerCopyright © 2011 John Wiley & Sons, Ltd. Int J Health Plann Mgmt 2011; 26: 296–318.
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importance of community mobilisation in behaviour change efforts. Critiquing
community‐focused approaches as being too narrow in their scope, Campbell and
Cornish (2010) argue that health‐related behaviours are often shaped by many factors
that lie beyond the boundaries of the local communities within which AIDS‐affected
people live andwork. They speak of the urgent need to develop systematic accounts of
the social contexts that frame community responses to health. Such a focus would
constitute a ‘fourth generation’ of approaches to HIV/AIDS management, one which
acknowledges the need to understand and target not only individuals and communities
but also the wider social contexts in which communities are located.
Campbell and Cornish (2010) provide a preliminary conceptualisation of three
dimensions of social context in which the members of AIDS‐affected communities
make health decisions, namely, the material, symbolic and relational dimensions of
their social environments. They developed this conceptualisation in the context of the
particular challenges of HIV prevention in South Africa and India, concluding that
there is a need to amend and develop their account of context in a wider range of
settings. In this paper, we use their framework as the starting point for our focus on
AIDS treatment.
As such, we take ‘material context’ to refer to the extent to which people have
access to the resources that they need to be healthy, including, for example,
opportunities for paid employment, access to food aid, microcredit schemes or
welfare grants. The ‘symbolic context’ consists of the meanings, the representations
and the ideologies that circulate within a society, including the representations of
gender and the presence or absence of AIDS stigma, which can either help AIDS‐
affected people cope (through enabling positive identity constructions and tolerant
and inclusive social relations) or be a source of social exclusion and discrimination
(Campbell et al. 2011c). The ﬁnal dimension of context described by Campbell and
Cornish (2010) is the ‘relational context’, referring to the quality of relationships and
partnerships between health service users, providers and funders as well as family
and community relations. It should, however, be said that all three dimensions are
intrinsically linked and reﬂect social relations within a community. If, for example,
stigmatising attitudes (symbolic) are common in a given community, this may
reﬂect poor social relations (relational), which in turn makes it harder for people to
negotiate access to support (material).
As the contexts of HIV prevention and treatment programmes differ, with, for
example, treatment programmes more dependent on health facilities and nurse–
patient relationships, we do not seek merely to adapt this three‐level framework.
Instead, we report on an empirical study that enables us to advance, expand and
redevelop the framework proposed by Campbell and Cornish (2010)—speciﬁcally
for the contextual analysis and action of ART adherence programmes in Africa.METHODOLOGY
The research question guiding this paper is: What social factors inﬂuence adherence
to ART? The study from which we seek to answer this question is ongoing and wasCopyright © 2011 John Wiley & Sons, Ltd. Int J Health Plann Mgmt 2011; 26: 296–318.
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and Imperial College London (ICREC_9_3_13). Informed and written consent was
gathered from all the participants with the agreement that their identities would not
be revealed. Pseudonyms have therefore been used throughout.
Study setup and sampling
This study was conducted in the Manicaland province of eastern Zimbabwe. The
impact of the AIDS epidemic on Zimbabwe has been devastating, but after peaking
with an HIV prevalence rate at 26.5% in 1997, the prevalence rate has stabilised and
was, in 2009, 14.3% (Zimbabwe Ministry of Health and Child Welfare, 2009). This
follows reductions in high‐risk behaviours between 1999 and 2004, and AIDS
mortality beginning to level off (Gregson et al., 2010). This study included
participants from three rural sites, all of which are characterised by high levels of
poverty. The majority of people living in these three communities are in informal
employment or survive through subsistence farming. The three health clinics serving
the communities all administer antiretroviral (ARV) drugs. The decentralisation of
ART services to include even smaller rural health clinics has helped Zimbabwe
provide treatment for 215 000 people (57% of those living with AIDS), and further
efforts are being made to increase uptake (UNAIDS, 2010). It was through the three
health clinics that we recruited our research participants. As Table 1 summarises, we
recruited 25 nurses and 53 adult ARV users. The ARV users were sampled using a
mix of snowball (using village community health workers), opportunistic (self‐
selected informants) and typical case (e.g. adherers to ART) sampling, and the
nurses were recruited on the basis of their willingness to participate in the study.
Data collection and analysis
Four experienced and Shona‐speaking researchers collected the data for this study in
October and November 2009. As illustrated in Table 1, they conducted 37
individual in‐depth interviews and ﬁve focus groups discussions, with the former
lasting on an average of 1 h and the latter 2 h and 20min. To keep the interviews
focused, the local researchers used semi‐structured topic guides, covering their
personal background, their experiences of AIDS, stigma and ART treatment as well
as the barriers and the facilitators of access and adherence to ART. The focus groups
discussions not only followed a similar topic guide but also engaged the participants
in a role play, demonstrating a typical patient–nurse interaction in an ART context.
With their consent, we digitally recorded the interviews, allowing us to transcribe
verbatim and translate the interviews into English. The transcripts were subsequentlyTable 1. Summary of participants and research methods
Participants Interviews FGD
Nurse 25 18 1
Patient 53 19 4
Total 78 37 5
FGD, focus groups discussions.
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(Berlin, Germany) for thematic content analysis (Flick, 2002).
Our analysis followed the steps of Attride‐Stirling’s (2001) thematic network
analysis. Step 1 was to code text segments with an interpretative title. This process
generated a total of ‘225’ codes. As we were not seeking to report on all of these codes,
we began, guided by the conceptual framework and reviews of the literature, to explore
how the codes are interconnected and identiﬁed dominant and relevant basic themes that
emerged from the codes (step 2). These basic themes highlighted some of the factors
inﬂuencing ART adherence. We then clustered these factors into higher‐order themes,
or the so‐called organising themes (step 3), giving rise to the dimensions of our
proposed framework.Weﬁnally clustered the organising themes into two global themes
(step 4), indicating two levels of analysis, namely, contextual and psychosocial. We
have illustrated this process in Tables 2 and 3, which outline each of the two levels of
analysis as well as the dimensions (organising themes) that came from our interviews
and their relationships. Through these steps, we have developed a data‐driven
conceptual framework of the contextual and psychosocial dimensions that inﬂuence
ART adherence. We will now turn to describe and elaborate on the emerging themes
(step 5), using the global and organising themes as the headings.CONTEXTUAL DIMENSIONS INFLUENCING ANTIRETROVIRAL
THERAPY ADHERENCE
In this rural context, remarkable progress has been made in the distribution of ART. Both
the patients and the nurses were very positive about the introduction and the scale up of
ART; however, they also agreed that many challenges were still outstanding. ART
requires much commitment and participation from patients. Once patients have tested
positive and experienced some of the ﬁrst and early symptoms of HIV/AIDS, they will
commence the treatment process. Their CD4 count levels are measured, and they are
counselled on the treatment regimen—which includes timely and daily administration of
the drugs. Patients will stay on ART for the rest of their lives and are in this context
required to show up for monthly review consultations where the nurses monitor the
patients’ progress and provide them with their monthly supply of ARVs. Although many
patients in our study, in principle, were committed to adhering, a number of contextual
factors shaped the likelihood that theywould do so in practice. Concurringwith Campbell
and Cornish’s (2010) framework, we found a number of material, symbolic and relational
factors to both undermine and facilitate ART adherence (See Table 2). In this paper,
however, we discuss the relational context from two perspectives where ‘relational’ refers
to personal relationships and ‘institutional’ refers to relationships with agencies.
Material
In the interviews, both the patients and the nurses referred to poverty as a key constraint
on adherence, impacting on the patients’ ability to take their drugs in a range of different
ways. Some of the more prevalent material dimensions inﬂuencing ART adherence
reﬂect the high levels of poverty that characterise the context of this study and primarily
refer to a lack of food and money compromising their treatment.Copyright © 2011 John Wiley & Sons, Ltd. Int J Health Plann Mgmt 2011; 26: 296–318.
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Codes Factors influencing adherence
(basic themes)
Dimensions
(organising themes)
• Poverty
• Food
• Distance to clinic
• Transport costs
• Hospital costs
1. Lack of adequate food, or fear of
supplementary food costs, stop
patients from taking their drugs.
2. Patients are more likely to attend
monthly consultations, and seek
urgent medical treatment, if the clinics
are nearby and transport is available
and affordable.
3. Many patients struggle to meet the
hospital costs associated with AIDS
treatment.
Material
• Stigma
• Gender roles
• Diminishing power
of traditional healers
4. Many patients feel stigmatised and
fear being recognised as an AIDS
patient, preventing them from seeking
ART services.
5. Notions of masculinity inhibit men
from participating in ART programmes
and can also prevent women from
adhering.
6. AIDS and ART are now part of the
public sphere. Everyone knows how to
prevent and treat AIDS.
7. As biomedicine proves its worth,
fewer patients see the need to consult
traditional healers.
Symbolic
• Social support
• Children
• Treatment partner
• Relationship with
nurses
8. Patients can optimise ART adherence
by drawing on support from community
members and friends.
9. Family members who act as
treatment partners can facilitate ART
adherence.
10. The quality of relationship that
patients have with health professionals
inﬂuences adherence.
Relational
• Churches and faith
• Food aid/NGOs
• Health service
improvements
• Counselling
• Waiting time and
opening hours
• Period lack of ARVs
11. Churches can both facilitate and
undermine ART adherence.
12. NGOs play an important role in
mobilising support groups and
providing food aid.
13. Good adherence depends on good
quality health services, including free and
readily available drugs, good counselling
and advice, favourable waiting and
opening times.
Institutional support
ART, antiretroviral therapy; ARV, antiretroviral; NGOs, non‐governmental organisations.
302 M. SKOVDAL ET AL.Inadequate access to food. A key component of the counselling and support that the
nurses provide to the ARV users involves their advice on the importance of patients
eating nutritional foods as part of their treatment regimen. ARVs work best ifCopyright © 2011 John Wiley & Sons, Ltd. Int J Health Plann Mgmt 2011; 26: 296–318.
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food, and witness little progress, coupled with the discomfort that comes with taking
powerful drugs on an empty stomach, some discontinued their treatment.
‘They say sometimes they don’t take their tablets if they don’t have something
to eat… it’s like there is this other female patient whom we initiated on ART,
so we gave her the two weeks starter pack, and when she came back she had
not taken the tablets, and we asked why, and she told us that she had not
enough food to eat before taking the tablets.’ Eddy, nurse
Distance to clinic and transport costs. Patients who cannot afford adequate levels of
food often also struggle to meet the transport costs associated with going to the health
clinic to attend monthly medical reviews and to pick up their monthly supplies of
drugs. This was particularly the case with patients who lived further away and who
had no other choice but to walk (because of either inadequate transport infrastructure
or the costs)—but often unable to ﬁnd the time and energy to make the journey.
‘Distance may discourage someone to come for medication. The patient might
say “a‐ah I’m tired of going all the way to the hospital” “a‐ah no I will go later”
and the person will be defaulting.’ Paul, nurse
In conditions of poverty, some patients had to travel from place to place to search
for support from various family members, which meant that it was often difﬁcult for
them to attend their monthly reviews and drug collections.
‘One patient said she had gone to Harare to visit her husband but she failed to
raise the money to come back here on time for her review, so for two months
she had no ARVs.’ Tonderai, nurse
An ARV distribution system that would allow patients to pick up drugs from any
health facility may help those patients who are on the move.Hospital costs. Aside from the costs related to getting to the clinics, the treatment
itself also came at a cost. This is despite the fact that the ARVs are given for free. The
three health facilities through which we recruited our informants all charged patients
$1 for their monthly consultation—a cost many patients struggled to meet.
‘Some patients fail to raise money for the transport to come and collect their
supplies and pay for their consultation fee. These are people who don’t have
any source of income. Sometimes they spend a lot of time trying to sell their
produce and they might forget to take their tablets.’ Alice, nurse
‘We are unable to raise that dollar every month when we go for reviews.’Austine,
patient
Patients who struggle with food and attending monthly consultations are less
likely to adhere and therefore more likely to experience opportunistic infections.
Although people can have free ARVs, they have to pay for the treatment of
opportunistic infections, a cost that is often so unaffordable that the patients do not
see anything to be gained from seeking medical advice.Copyright © 2011 John Wiley & Sons, Ltd. Int J Health Plann Mgmt 2011; 26: 296–318.
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infection that will prevent me from going to the clinic in the ﬁrst place.’ Agnes,
patient
In relation to material context, it was clear that poverty severely undermined ART
adherence and in some cases put ART users at risk of experiencing viral replication
and the advancement of AIDS (e.g. through lack of food or untreated opportunistic
infections). We will discuss how some patients overcome these problems in the next
section, for example, by engaging in IGAs.
Symbolic
Various dimensions of symbolic context appeared to serve as both barriers and
facilitators of adherence. The barriers discussed below include fear of being
recognised as an AIDS patient, reﬂecting a continued presence of stigma and
women’s disempowered position within their household. The facilitators included
the growing awareness of AIDS and ART as well as a diminishing dependence on
traditional healers, whose advice was seen by many to contradict the biomedical
advice that they saw as more useful in their current condition.
Fear of being recognised as an AIDS patient. Although many patients reported that
since the advent of ART there had been a reduction in the stigmatisation of
PLWHA, many patients, particularly men, spoke of feeling the fear and the
embarrassment associated with being recognised as an AIDS patient, saying that
stigma served as a barrier to the timely accessing of services by many men.
‘Men are generally afraid to be identiﬁed as HIV positive. They are shy and they
may only “come out” after they get seriously ill. Some are afraid that people will
laugh at them or look down upon them for being HIV positive.’ John, patient
Once enrolled onto ART, many men were deterred from attending the monthly
consultations that required them to go to the ‘AIDS clinic’ and wait in long queues
together with other AIDS patients. In such a situation, they were unable to keep their
status a secret, and many found this prospect intolerable.
‘People know that this is the AIDS clinic. Some patients when they come here,
they will go past the place. Then when they see me going out of the clinic, perhaps
to go for tea, they will approach me secretly to ask me privately to attend to them.
When I ask him to come into the clinic hewill be distressed to see that there is “Mrs
so and so” on the bench, whom he did not want to “come out” to.’Claudius, nurse.
Women’s disempowered position within households. In this context, women’s
social and often disempowered position stands in the way of their ability to adhere to
treatment. Bridget had travelled from Manicaland to see her husband, a migrant
worker lodging in Harare, to collect money for their children’s school fees.
However, her husband decided to spend the money on his girlfriends, refusing to
give her the money she would need to travel back to Manicaland to collect her ARV
treatment.Copyright © 2011 John Wiley & Sons, Ltd. Int J Health Plann Mgmt 2011; 26: 296–318.
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after work—to give me money so that I could travel back to the rural area.
However he did not come back to his lodgings. He took his money from work
and went to his girlfriend’s place. The second month he did the same thing. It
was only in the third month that he gave me money so I could travel back.
When I came back home after the third month I went to the clinic and
explained to them that I hadn’t been able to take my treatment for almost three
months, because my husband would not give me the money to come back. The
nurses were not impressed—but I was honest and they tried to help me, that’s
why I had to go for CD4 tests again.’ Bridget, patient.
Bridget’s economic dependence on her unreliable husband highlights women’s
marginalised position in this context. The husbands’ unwillingness to accept their
wives’HIV status, and to support their treatment, can sometimes result in women being
threatened with divorce if they insist that they are HIV positive in the face of their
husbands’ disbelief and if they express determination to adhere to their ART treatment.
‘Some men refuse to believe that their wives are HIV positive. They
themselves refuse to come to the clinic and get tested. Sometimes, if the wife
comes here to get services, the husband will threaten to divorce the wife if she
continues taking ARVs. This will affect her adherence.’ Claudius, nurse
This suggests that women’s economic dependence on men, facilitated by local
constructions of gender, can serve as a barrier to women’s adherence.AIDS and antiretroviral therapy in the public sphere. In an effort to curtail the AIDS
epidemic, many information campaigns have sought to educate the general public
regarding how AIDS is spread and what treatment opportunities are available—
imprinting AIDS into the public sphere.
‘People now know that there is this disease. It is talked about on radio and
television, people being told when to take pills and that these pills can help, that
condoms can help you to prevent HIV. Condoms are encouraged on the radio,
and nurses in hospitals speak about not having too many partners.’ Joe, patient
A recent WHO study suggested that 45% of Zimbabwean youth aged 15–24 years
are in possession of comprehensive and correct knowledge of HIV/AIDS (WHO,
2010), testifying to the fact that the ‘wall of silence’ and denial that characterised the
epidemic’s earlier stages are gradually coming down, and AIDS is increasingly
being acknowledged as a fact of life. This increasing social acknowledgement of the
problem, coupled with the fact that contracting AIDS is no longer a death sentence,
has made it easier for some people to be tested and to accept their HIV status.
‘People now have the information and are now encouraging each other to go
for HIV tests. People now know that there are ARVs and if one tests HIV
positive then there is hope because ARVs are now available.’ Chris, patient
As AIDS transmission and treatment technologies become part and parcel of the
public sphere, people’s faith in unhelpful traditional interpretations and ‘cures’ diminish.Copyright © 2011 John Wiley & Sons, Ltd. Int J Health Plann Mgmt 2011; 26: 296–318.
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somehow been affected by AIDS and have some knowledge about the disease.
This has meant that fewer people are resorting to traditional cures and explanations
such as witchcraft, which were common at the earlier stages of the epidemic, and,
with the introduction of ART, are appreciating the potential of biomedical
technologies—giving them less reason to visit traditional healers.
‘When I ﬁrst fell ill, I believed it was witchcraft, I did not know better.When I was
then tested for HIV and found to be positive I felt relieved. I toldmy relatives not to
go witch hunting if I die, knowing I will die from AIDS. Normally people would
go to a witch doctor if their relative dies to ﬁnd who really has caused the death. I
then went through the whole process and I am now on ARVs and I am recovering
well. I don’t see the beneﬁt of going to a traditional healer.’ Violet, patient
Relational
ART adherence is heavily inﬂuenced by the social relationships that exist between
ART users and the people they interact with on a daily basis, including family and
community members as well as service providers. In this subsection, we highlight
the important role played by social support, treatment partners and sustaining good
relationships with nurses in facilitating adherence.
The availability of social support. In conditions of poverty, a key contributing
factor to ART adherence is social support. One patient highlighted how people in his
village have organised themselves so that they all support one another.
‘The best thing about my village is the way we are living. When it comes to
ploughing, people share knowledge so that they can plant for themselves and sell
to each other. People are encouraging each other to take their children to school. If
there is anyone who is sick, and the relatives have died, people will come and
help.’ Karren, patient
In addition to support from community members, the patients participating in this
study also spoke about the importance of support from other ART users in providing
encouragement and advice. Such support was available both through support groups
and through friends.
‘We have our support group and I have a friend who always encourage me and
try to make me have a positive attitude when I am down. I also do the same
with fellow HIV sufferers. We try to up lift each other.’ Everline, patient
Family support and treatment partners. Also, family members play an integral part
in a patient’s adherence to ART. As the testimonies from Christine and Garikai
suggest, it is crucial that family members are aware and have an understanding of
their treatment regimen so that they can help remind the patient about when to take
drugs and when to attend consultations.
‘My family encourages me and urge me not to miss my appointments because
they now appreciate how these drugs have helpedme to recover.’ Pamela, patientCopyright © 2011 John Wiley & Sons, Ltd. Int J Health Plann Mgmt 2011; 26: 296–318.
DOI: 10.1002/hpm
307INFLUENCES ON ART ADHERENCE IN RURAL ZIMBABWE‘The way some patients live, say for example they might staying with people who
look down upon them, or they could be livingwith peoplewho don’t even take this
programme seriously, so there wouldn’t be anyone to remind them.’ Alice, nurse
Family members were also found to play an important role in ensuring that the
patients had sufﬁcient food and were emotionally supported.Relationship with nurses. Both nurses and patients spoke about the qualities and the
characteristics of a ‘good patient’, indicating the importance of patients conforming to
the norms of the ‘good patient persona’. This required some level of relationship
building between patients and nurses, which could result in either productive and
health‐enabling patient–nurse relationships or a breakdown in communication, which
could be detrimental to the patient who would end up fearing going to see the nurse.
‘I think a patient who follows what the nurse advised is the patient they think is
good. A patient who takes all the tablets as directed and completes the course as
well as coming back for reviews. A patient who adheres to what the nurses who
have taught, to the nurses this will be a good patient I think.’ Albert, patient
‘A good patient will never miss their appointments or even default on their time
of taking pills because they understand why they are taking those pills and they
also don’t want to spoil their relationship with us.’ Joe, nurse
It was evident that social relationships play a key role in facilitating or undermining
ART adherence.
Institutional support
At an institutional level, churches, non‐governmental organisations (NGOs) and
health services all inﬂuence a patient’s ability to adhere to ART.
Churches inﬂuence antiretroviral therapy adherence. Our informant’s had mixed
responses to the role of their church in facilitating or undermining ART adherence.
The Apostolic Church was often cited for ignoring the impact of AIDS and
discouraging its followers to take medicines. However, not all churches and
denominations were a barrier to ART. Some churches actively discouraged
traditional medicines and healing and promoted AIDS testing and ARVs.
‘What discourages some people to take their tables is the church. Many churches
don’t encourage people to go to the hospital […] The church that I attend is different,
they don’t allow traditional medicine so I now rely on pills only.’ Karren, patient
Non‐governmental organisations’ role in mobilising support. A number of faith‐
based and international NGOs worked actively in the area of study. The organisations
were reported to be providing people with AIDS information and to be supporting
those who are already on ART. Aside from training community health workers and
providing encouragement for PLWHA, NGOs were found to distribute food to ARV
users—an activity that provided an incentive for non‐ARV users to go and be tested.Copyright © 2011 John Wiley & Sons, Ltd. Int J Health Plann Mgmt 2011; 26: 296–318.
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like food, I would say when home based care, actually AFRICARE initiated
food handouts as well as Plan International, people started ﬂocking here to
come and get tested, they wanted to know whether they are HIV positive or
not. Almost everyone came for testing.’ June, nurse
Many of the services provided by NGOs were co‐ordinated with the local health
clinic to ensure that their services reached ARV users.
Quality of health services. With the ARV roll‐out came the training of nursing staff
and a decentralisation of CD4 count machines to speed up ARV reviews. All of
these, together with the availability of free ARVs, have improved people’s trust and
perception in the quality of healthcare services available to them.
‘Many people can now access ARVs for free. Before people were worried about
the CD4 cell tests which used to be done in Mutare Town before our local clinic
got the machine. Previously, patients would need to come twice before getting
their results processed. This inﬂuenced the treatment of some people. But since
we got the CD4 count machine we have been running smoothly.’ Colin, nurse
Having said this, despite the progress that has been made, many challenges
remain, including the shortage of health staff. One patient explained how staff
shortages (resulting in long waiting times) can discourage patients from going for
their check‐ups.
‘There are times when we feel it is impossible to see a Doctor, and one might as
well just discontinue treatment and stop going there only to waste time waiting in
the queue.’ Rose, patient
Other challenges faced by the health services, undermining the quality of services
available to ARV users, include continued resource constraints, poor management,
difﬁculties with repairing dysfunctional equipment, power cuts and limited access to
water. This subsection has underlined some of the pathways through which the
availability and quality of institutional support can inﬂuence ART adherence.
The above dimensions of context can all inﬂuence ART adherence. However,
they also provide the platform through which psychosocial behaviours are enacted.PSYCHOSOCIAL DIMENSIONS INFLUENCING ADHERENCE
In addition to the contextual dimensions discussed above, our analysis also revealed a
number of psychosocial dimensions inﬂuencing ART adherence. However, the
psychosocial dimensions that inﬂuence ART adherence appear to be intertwined with
the contextual dimensions discussed above. In this section, we explore different forms
of behaviour inﬂuencing ART adherence but argue that they are enabled or limited by
the context. As Table 3 illustrates, we have identiﬁed three broad psychosocial
dimensions to inﬂuence ART adherence. The ﬁrst relates to patients motivation for
taking ARVs. If a context allows a patient to readily access ART and the patient
experiences improved health, the patient may feel motivated to carefully adhere to theCopyright © 2011 John Wiley & Sons, Ltd. Int J Health Plann Mgmt 2011; 26: 296–318.
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treatment by engaging in activities that are conducive for their treatment. The third and
ﬁnal dimension relates to patients’ psychosocial responses to ART. Depending on the
context and the levels of support available, patients may engage in health‐damaging
activities, such as drinking alcohol, in an attempt to avoid their reality. Others may be
able to construct positive social identities. We will now discuss the psychosocial
dimensions in more detail, following the structure illustrated in Table 3.
Patient motivation
How patients experience the physiological impact of ART differs—conditioned by
their local context—and impacts their motivation for taking drugs. This can either
facilitate (if patients experience improvements) or undermine (if patients suffer from
repeated side effects) ART adherence.Table 3. Global theme: psychosocial dimensions inﬂuencing adherence
Codes Factors influencing adherence
(basic themes)
Dimensions
(organising themes)
• Seeing improvements
• Side effects
• Taking responsibility
• Hope
• Desire for life
• Habit
• Complacency/
negligence
14. Patients are encouraged to stay on
ART when they experience improvements
to health.
15. Hope and having reasons to live a
healthy life facilitate ART adherence.
16. With time, patients may be into the
habit of taking drugs or they may become
complacent and stop taking them.
17. Patients may decide to stop taking
ARVs if the side effects become too severe.
Patient motivation
• Disclosure and denial
• Mobilising support
• Income generation
• Agency
18. Actively disclosing HIV status
facilitates adherence as people around
the patients support them.
19. Some patients actively create social
spaces to facilitate their adherence.
20. Some patients actively engage in
income‐generating activities to sustain
the healthy diet required for ART.
Patient participation
• Depression
• Alcohol
• Spiritual beliefs and
traditional healing
• Conﬁdence
• Positive identities
• Psychosocial
problems
21. Some patients, men in particular,
resort to alcohol to avoid a reality as
an HIV‐positive individual.
22. Patients may turn to non‐biomedical
resources for support, some of which
may hinder or support adherence.
23. Many patients develop conﬁdence
in their ability to take control over their
health and begin to construct positive
social identities, differentiating
themselves from those who have not yet
been tested.
Psychosocial
responses to ART
ART, antiretroviral therapy; ARV, antiretroviral.
Copyright © 2011 John Wiley & Sons, Ltd. Int J Health Plann Mgmt 2011; 26: 296–318.
DOI: 10.1002/hpm
310 M. SKOVDAL ET AL.Seeing improvements. Both nurses and patients frequently spoke about the positive
impact that ART had on health and well‐being of ARV users. ART has enable many
patients from being weak and bedridden to being ﬁt and productive—a change in
health which motivates many to adhere.
‘I feel motivated by the mere fact that before I was on ART I was always sick
and was unable to do a lot of chores but since I started taking these drugs I am
ﬁt again.’ Lucy, patient
One very visible change that ART can bring about is the weight gain of patients.
In this context, looking sickly thin is associated with AIDS, and because ART can
facilitate weigh gains, patients who were previously perceived as sick (and subject
to stigma) now look healthy and well. The weight gain that ART can facilitate
therefore inﬂuences ART adherence positively.
‘Some of them might have been motivated by the recovery they have gained.
Especially those who have gained some weight think they might lose weight
again if they default.’ Eddy, nurse
Hope and desires for life. Seeing improvements to health after being diagnosed with a
disease that is often associated with death gives patients hope and a new and more
positive outlook on their lives and their futures.One nurse argues that the life‐prolonging
opportunities that ART provide is a key reason to why some patients adhere to ART.
‘Adherence is successful when patients are taking medication so that they can
live longer.’ Marta, nurse
Also related are the reasons why patients have to live a long and healthy life.
Janet, for example, knows that only by adhering to ART will she stay healthy
enough to care for her children and see them grow up.
‘My kids are still very young and I value my health because it’s only when I am
ﬁt that I can look after my children. I still want to look after children, so I stick
to what the doctor advises me to do. I keep all my review dates, and I check my
diary regularly so that I don’t miss any review dates.’ Janet, patient
Habit and complacency. How patients experience ART changes with time—
changes that may either facilitate or undermine ART adherence. As Natashia
highlights, many patients become used to their treatment regimen, and taking drugs
becomes a habit that they do not need reminding of.
‘We get accustomed to the routine of taking those drugs’ Natashia, patient
On the other hand, you have patients who, after experiencing positive changes
to their health, become complacent and believe they have recovered from AIDS.
‘I have also realized that there is also a problem with patients who would have
been on ART for a long time and now feeling like they are recovered. I have
discovered that they become reluctant and their rate of compliance also goes
down. May be they will be feeling that they have fully recovered and have
been cured, so sometimes getting ill will help them to comply.’ Esther, nurseCopyright © 2011 John Wiley & Sons, Ltd. Int J Health Plann Mgmt 2011; 26: 296–318.
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people. For a small minority, the healthmay deteriorate as a result of ART—for example,
through developing Steven–Johnson syndrome (toxic epidermal necrolysis), which is a
skin disease. But for the majority, discomfort arising from the physiological reactions to
the powerful drugs iswhatmakes somepatients decide to discontinue their drug regimen.
‘I stopped taking ARVs because of the side effects. This is my 5th time trying
these ARVs. The ﬁrst time, I was on ARVs, they worked well for 3weeks, but
then some painful reactions appeared—burns started developing. That was
when I stopped and was given some medication to deal with the reaction and
when I was feeling better again they tried me again.’ Marie, patient
The nurses reported that the negative side effects ofARTwere higher amongst patients
who had inadequate food. Although the side effects may only encourage patients to
discontinue their treatment temporarily, it is such inconsistencies that cause drug
resistance.
Patient agency
ART does not improve health in a vacuum but reacts to the various contextual
dimensions that facilitate adherence. Patients can therefore take an active and
mediating role in ensuring that the context is conducive to ART adherence.
Disclosing their need for treatment. One important psychosocial factor facilitating
ART adherence is the patients decision to disclose to others their HIV status and
need for ART. Patients who tell the people close to them about their status and
treatment regimen do not need to take their pills secretly—something that can result
in treatment defaults.
‘There are some who still want to keep it secret that they are living with HIV.
Yes, it is their decision but such people might even default because they would
be trying to make sure they are not seen.’ Vincent, nurse
We have previously discussed how telling those around you, for instance, family
members or those whom they live with, can be an invaluable resource for ARV users as
they can provide encouragement and help remind the patients about taking the drugs
and attend consultations.
Ability to mobilise support. In the preceding paragraphs, we have discussed the
importance of social support. However, social support is not just something that is
always available for patients to draw on; it requires patients to negotiate and navigate
through the kinds of support that are available. Patients therefore beneﬁt from living in a
context that allows them to actively mobilise and access social support. In our context,
this can be illustrated through the way in which support groups for ARV users are
emerging—often as a result of their initiative and active participation.
‘HIV positive people here are organized and we have our support group. It is so
encouraging to have an arrangement whereby we meet on regular basis as
people living with HIV/AIDS.’ Everline, patientCopyright © 2011 John Wiley & Sons, Ltd. Int J Health Plann Mgmt 2011; 26: 296–318.
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that help them cope with the challenges to ART adherence. This includes sharing
knowledge about the IGAs they do.
Engage in income‐generating activities. Patients’ engagement in IGAs signiﬁes a
number of important factors that inﬂuence ART adherence. Firstly, patients are able to
engage in IGAs because of the improvements in health they have experienced as a result
of ART. Secondly, IGAs provide ARV users with a platform to prove their productivity
and worth to society and to develop a positive approach to being HIV positive. Finally,
the IGAs allow the patients to grow healthy and nutritious foods—all of which facilitate
ART adherence.
‘MyHIV positive status gaveme the inspiration to start participating inHIV/AIDS
programmes, and I developed this positive approach, and I decided to start some
income generating projects. I remember I started a poultry project and vegetable
garden at our rural homewhich is near here. I grow carrots and have some chicken.
I do this for myself so that I can eat healthy food. All these projects I started them
after realizing that I am HIV positive and I would need a good diet and a little
income.’ Tonderai, nurse
This subsection has highlighted the role patients can play in optimising the outcomes
of their treatment. This suggests that ART‐enabling contexts must be conducive and
supportive of the kind of activities and participation that facilitate ART adherence.
Psychosocial responses to antiretroviral therapy
In this ﬁnal subsection, we will explore how different patients respond psychologically
to their HIV status and need of treatment.
Drinking alcohol to avoid reality. A challenge particular to men in this context is the
local constructions of masculinity, which makes it difﬁcult for men to accept their HIV
status and need for treatment. Many men fear that being HIV positive will reduce their
manhood and status and therefore often resort to alcohol to avoid a reality where they
see themselves to have a lesser role and purpose.
‘It is common with men… adherence is hard to achieve for men because of
alcoholism. Some men will drink so much that they forget to take their drugs,
and even forget that they are patients on ART.’ Colin, nurse
Although many of our male participants reported on masculinity as a barrier to ART
adherence, often with reference to alcohol use, they themselves had overcome these
barriers—suggesting that far from all men struggle to come to terms with their HIV
status and need to adhere to ART.
Spiritual advice and traditional healers. Some patients resort to the spiritual world
for advice and to give meaning to changes in their lives. Although some churches are
unhelpful in providing support to ART users, many patients still look towards faith to
ﬁnd encouragement and meaning to difﬁcult circumstances—providing them with
positive attitudes and outlook on life, which can facilitate ART adherence.Copyright © 2011 John Wiley & Sons, Ltd. Int J Health Plann Mgmt 2011; 26: 296–318.
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that you get and the encouragement that you are not the only one in this
situation you notice that it gets rid of the negative thinking that you had that
might have deteriorated your health or your life you see.’ Nicola, patient
Others may use faith and spiritual advice differently, hoping that it can provide a
cure for AIDS. Such patients, as one nurse illustrates, are more likely to periodically
discontinue their treatment—presenting a barrier to ART treatment.
‘This one ART patient of mine decided to consult a traditional healer, when she
got there she was told that she was not HIV positive and she should stop taking
those ARVs and was given some concoction, that she was told would cure her
illness all together. So she stopped coming here, and when she came here she
had deteriorated so much.’ Esther, nurse
Constructing empowering social identities. The availability of ART has provided
some patients with a renewed and empowering identity—one that draws on the
health gains they have experienced as a result of ART, which translates AIDS from a
death sentence to a chronic and manageable disease. Through an ‘us and them’
distinction, a number of ARV users highlighted themselves as responsible citizens
who are now worthy of respect from ‘the other’.
‘Now people with HIV are able to feel like any other ﬁt person… these drugs have
removed signs and symptoms of HIV and made us healthy again, gaining the
respect of other people in the community who would have condemned us to death.
It has made us ﬁt again, as you might as well know we could have died or been
bedridden by now. The drugs have brought life and restored dignity to us. People
no longer look down upon us that much.’ Pamela, patient
This subsection has explored some of the representations and the meanings that
ARV users draw on as a response to their ART treatment. Depending on the
individual patient, these representations and meanings can facilitate or undermine
their adherence to ART and are worthy of our attention.
DISCUSSION
A great number of studies have explored the structural and behavioural barriers and
facilitators to successful ART adherence. They have provided us with very useful
snapshots of the determinants of successful treatment compliance in various contexts.
Many of the barriers or the facilitators we refer to here have been identiﬁed in other
contexts. These include lack of adequate food, transport costs, waiting times, side
effects and fear of stigma (Mshana et al., 2006; Hardon et al., 2007; Murray et al.,
2009) as well as the role of alcohol, family members and treatment partners, social
support and personal motivation to treatment (Dahab et al., 2008). However, our
analysis has revealed the existence of several additional factors including the role of
patient/nurse relationships as well as gendered positions in facilitating or undermining
ART adherence. We are reporting on these factors in greater detail elsewhere
(Campbell et al., 2011a, Skovdal et al., in press, Skovdal et al., 2011).Copyright © 2011 John Wiley & Sons, Ltd. Int J Health Plann Mgmt 2011; 26: 296–318.
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inﬂuencing ART, we have in this paper, as the ﬁrst of its kind in Zimbabwe,
presented a broad spectrum of barriers and facilitators to ART adherence, all of
which can tell us a great deal about how we can improve compliance to AIDS
treatments. Informed by ‘the health‐enabling social environment’ model, we have
highlighted the networks and the relationships between some of the most prevalent
inﬂuences to ART adherence in our case study. We did this with the aim to develop
a framework that can assist with the analysis, planning and execution of ART
programmes in other African contexts. As detailed by the structure of our discussion
of ﬁndings, the framework we have developed consists of four contextual and three
psychosocial dimensions. Table 4 summarises our proposed analytical framework.
Through this framework, we propose that attention should be given to the
contextual and psychosocial dimensions that can inﬂuence successful compliance to
treatment. We thereby provide ART programme planners and implementers with a
tool that encourages them to analyse the content of each of the seven dimensions
outlined in Table 4. The content of the contextual and psychosocial dimensions will
differ between socio‐economic and cultural settings; however, our study, and the
numerous other studies that have looked at ART adherence in Africa, provided
useful pointers towards what the content of the seven factors that we have identiﬁed
to inﬂuence ART adherence might be.
In our case study, thematerial context refers to how poverty and sources of economic
and materialistic support inﬂuence patients’ ability to adhere to ART. In our study, this
translated into lack of food and difﬁculties meeting the costs associated with treatment.
In agreement with a recommendationmade by Adato and Bassett (2008), these ﬁndings
suggest that there is an urgent need to include ARV users in social protection schemes
such as food and cash transfers. The symbolic context highlights some of the meanings
and the representations that ﬂourish in a given context and inﬂuence ART adherence.
Although we found that widespread and improved knowledge of AIDS (highlighting
the importance of information) has diminished the role of traditional healers, gendered
stereotypes and fear of stigma still undermined ART adherence of men in particular.
These ﬁndings have highlighted the importance of creating social spaces that can
challenge and strengthenmeanings and representations in such away that patients begin
to ascribe positive value and meaning to otherwise difﬁcult circumstances (Goudge
et al., 2009; Campbell et al., 2011b). The relational context refers to social relations,
both within and between families, community groups and organisations. Although this
may also include forms of leadership, our case study was limited in scope to only
include the relations between the patient and his or her social environment, including
family and community members and nurses at the hospital. The inﬂuence of social
relations on ART adherence was the focus of a study by Ware et al. (2009) who argue
that social relations can explain the favourable ART adherence rates found in Africa.
Needless to say, the institutional context plays a fundamental role, particularly when it
comes to the availability and the quality of health services. Numerous studies have
explored how the quality of health services inﬂuence ART uptake and adherence
(McCoy et al., 2005; Kip et al., 2009; Nsigaye et al., 2009). However, as illustrated
from our case study, other institutional actors that may inﬂuence compliance to AIDS
treatment include NGOs and churches. Our study highlighted different aspects toCopyright © 2011 John Wiley & Sons, Ltd. Int J Health Plann Mgmt 2011; 26: 296–318.
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Inﬂuences on ART adherence
Contextual dimensions Psychosocial dimensions
Material Symbolic Relational
Institutional
support
Patient
motivation
Patient
participation
Psychosocial
responses
to ART
For example
• Access to
food
• Distance
to clinic
• Transport
costs
•Treatment
related
costs
• Fear and
stigma
• Gender
constructions
• AIDS and
ART in
public sphere
• Inﬂuence of
traditional
healers
• Social
support
• Family
support
and
treatment
partners
• Patient/
nurse re-
lationships
• Support
from
churches
• Support
from NGOs
• Quality
of health
services
• Seeing im-
provements
• Hope and
desire for life
• Habit and
complacency
• Experienc-
ing side
effects
• Status and
need for
treatment
• Mobilising
social sup-
port
• Engaging
in income‐
generating
activities
• Alcohol
abuse
• Spiritual
advice
• Construct-
ing empow-
ering social
identities
ART, antiretroviral therapy; NGOs, non‐governmental organisations.
315INFLUENCES ON ART ADHERENCE IN RURAL ZIMBABWEpatient motivation, underlining the importance of its role as a psychosocial dimension
to successful treatment compliance. What motivates patients to (dis)continue taking
medication differs and happens at a reﬂexive and non‐reﬂexive level. At the reﬂexive
level, patients are motivated by seeing improvements to their health (value of
treatment) and how this positively impacts on their role as wives, husbands or parents.
On the other hand, patients may be demotivated by the side effects that may arise as a
result of the medication. At a non‐reﬂexive level, patients may get into a habit of taking
their medication, or they may be complacent and thereby discontinue taking their
medication. Patient participation highlights the different initiatives that patients
engage in, in interaction with their local context, to achieve optimal health outcomes.
Such initiatives include disclosing their status and need for the ART as well as their
participation in support groups and income‐generating projects. Although the need for
ARV users to disclose their HIV status has been discussed elsewhere (Sanjobo et al.,
2008), little attention has been given to the active participation of patients in sustaining
their treatment. In a forthcoming study, we discuss how patients negotiate a ‘good
patient’ persona in order to achieve the best possible care from nurses (Campbell et al.,
2011a). The ﬁnal psychosocial dimension of this framework refers to the patient’s
psychosocial responses to ART and involves the different ways in which patients react
and respond psychologically to the treatment regimen. Again, we found the patients to
respond differently. Some patients, particularly men, sought to avoid the perceived
grim reality of having lost their manhood to AIDS, repeatedly reminded to them by
their daily drugs, by excessive drinking of alcohol. On the other hand, men and women
were found, through social spaces and with each other’s help, to have developed new
and empowering identities that help them give meaning and purpose to life.
Several potential limitations of this study exist. The framework we have presented in
this paper is by nomeans complete, and we encourage other researchers to both exploreCopyright © 2011 John Wiley & Sons, Ltd. Int J Health Plann Mgmt 2011; 26: 296–318.
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groups and geographical settings—adding on to our contextual and psychosocial
levels of analysis. We are also not saying that the content of the dimensions will be
the same in every context. Given that our data were collected mainly in rural areas
of eastern Zimbabwe with Shona‐speaking participants, we concur with Flyvbjerg
(2001) that the generalisability of ﬁndings to other locations should be established
on a case by case basis. Nevertheless, although the content of the dimensions
presented in this paper will differ between contexts, we believe that the framework
provides a useful starting point for programme planners to examine the inﬂuences
that may compromise or facilitate successful compliance to ART in any resource‐
poor context.CONCLUSION
In summary, this study has reported on some of the more prevalent barriers and
facilitators to ART adherence in Zimbabwe and classiﬁed them into a framework
that is transferrable for the analysis and action of ART programmes elsewhere. The
framework argues that ART programme planners and implementers need to pay
attention to four contextual (material, symbolic, relational and institutional) and
three psychosocial (patient motivation, patient participation and psychosocial
responses to ART) dimensions in their analysis of factors that may facilitate or
undermine successful compliance to AIDS treatment in Africa.
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